Products

Rayvolve
AZmed SAS
Radiology & Imaging AI
Rayvolve by AZmed is an FDA-cleared AI software suite for X-ray diagnostics, offering rapid and accurate detection of fractures and chest pathologies for adult and pediatric patients. It integrates seamlessly into existing radiology workflows, significantly reducing interpretation time and diagnostic errors.

See all 1 product →

About AZmed SAS

AZmed is a European MedTech startup, founded in 2018, that is dedicated to revolutionizing medical imaging through AI-powered solutions. The company’s flagship AI suite, Rayvolve®, is designed to enhance radiological diagnostics by improving accuracy and saving valuable time for healthcare professionals. Rayvolve® includes FDA-approved and CE-marked solutions that streamline radiology workflows by prioritizing critical cases and accelerating treatment planning. AZmed’s deep learning technologies are fully integrated into doctors’ workflows, aiming to optimize daily productivity and improve patient care pathways without requiring changes in existing work habits.

For physicians, AZmed’s Rayvolve® AI suite offers specialized tools such as AZtrauma, a leading AI radiology solution for detecting fractures, dislocations, and joint effusions on X-rays, which has been clinically validated by top institutions. AZchest, also clinically validated and FDA-cleared, automatically categorizes, detects, and reports major cardiac and lung abnormalities on X-rays, including lung nodules, pneumothorax, and pleural effusion, demonstrating high sensitivity and specificity. Additionally, AZmeasure provides automated characterization of osteo-articular geometries, and AZboneage offers advanced automated calculation of bone age for pediatric patients based on the Greulich & Pyle methodology. These tools are developed to assist radiologists and emergency physicians in making more efficient examination interpretations and reducing the risk of diagnostic errors.

Focus Areas

AI-powered medical imaging X-ray diagnostics fracture detection chest X-ray analysis lung nodule detection pneumothorax detection pleural effusion detection radiology workflow optimization diagnostic error reduction

Business Intelligence

Key InvestorsAlbo Club, Maison Worms, Teampact Ventures, ACT (Riyadh), The Future Investment Initiative Institute, Techstars
PartnershipsRADIN Health, UP Centre for Paediatric Emergencies, Radiologie Dix30, GE Healthcare, Fujifilm, SimonMed Imaging, NHS, UH Cleveland Medical Center, CHIREC
TechnologyCloud-native AI operating system, deep learning algorithms, integrated with PACS & RIS, Rayvolve® AI Suite
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

AI-Powered Medical Imaging
AZmed specializes in AI-powered medical imaging, leveraging deep learning and computer vision technologies to analyze X-ray and CT scans.
Fracture Detection (AZtrauma)
Their AZtrauma solution detects all types of fractures, dislocations, and joint effusions on X-rays for all age groups, including pediatric patients. It boasts high sensitivity (96%) and specificity (86%) for pediatric fractures.
Chest X-ray Analysis (AZchest)
AZchest is designed for comprehensive chest X-ray analysis, automatically detecting, categorizing, and reporting on cardiac and pulmonary abnormalities such as consolidation, pleural effusion, cardiomegaly, acute pulmonary edema, pneumothorax, and lung nodules.
Lung Nodule Detection (AZchest & AZnod)
AZmed offers lung nodule detection on both X-rays (AZchest) and CT scans (AZnod). AZnod provides standardized characterization of nodules (3-30mm), including volumetric measurements, precise diameters, anatomical location, and morphological features.
Pneumothorax & Pleural Effusion Detection (AZchest)
AZchest provides high-performance detection and triage capabilities for pneumothorax (93.79% sensitivity, 98.57% AUC) and pleural effusion (91.34% sensitivity, 98.30% AUC) on chest X-rays.
Radiology Workflow Optimization
AZmed's solutions are designed to streamline diagnostic workflows, increase efficiency, and reduce reading times (e.g., up to 35.8% reduction with AZchest, 27% with Rayvolve for fractures), by prioritizing urgent cases.
Diagnostic Error Reduction
Their clinically validated tools significantly reduce diagnostic errors, with studies showing a reduction in false negatives (e.g., 67% avoided with Rayvolve for trauma) and an overall improvement in diagnostic accuracy.
Physician Tip

For physicians, AZmed's AI solutions act as a reliable 'second reader,' significantly enhancing diagnostic accuracy by flagging subtle findings that might otherwise be missed. This leads to earlier detection of critical conditions like lung cancer and fractures, enabling faster treatment initiation and improved patient outcomes. The integration into existing PACS/RIS systems means minimal disruption to current workflows, while the automated prioritization of urgent cases and reduction in interpretation time helps alleviate radiologist workload and combat burnout, allowing more focus on complex cases and direct patient care. The standardized reporting features also contribute to more consistent and reproducible assessments. The pediatric clearance for fracture detection is particularly valuable for emergency and trauma settings.

AZmed's solutions are designed for seamless integration into existing radiology Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS). They interact directly with DICOM Node servers, processing images and returning AI-annotated results or structured reports without requiring changes to current work habits. This plug-and-play approach ensures easy adoption and minimizes workflow disruptions. They are compatible with the DICOM image standard.

Products by AZmed SAS

1 product in the directory

Rayvolve
AZmed SAS
Radiology & Imaging AI
Rayvolve by AZmed is an FDA-cleared AI software suite for X-ray diagnostics, offering rapid and accurate detection of fractures and chest pathologies for adult and pediatric patients. It integrates seamlessly into existing radiology workflows, significantly reducing interpretation time and diagnostic errors.

What the Web Says

AZmed SAS is a French company founded in 2018 that develops AI-powered solutions to enhance X-ray diagnostics, aiming to improve accuracy and efficiency for healthcare professionals. Their flagship product, Rayvolve, is an AI-driven radiology platform designed to streamline diagnostic workflows, improve diagnostic precision, and reduce workload burden by rapidly interpreting imaging data. AZmed's products, such as AZchest and AZtrauma, have received FDA clearance and are used in over 55 countries and 2,500 healthcare centers.

Overall: Positive

Strengths

  • AI-driven platform increases workflow efficiency and improves diagnostic precision.
  • Products like AZchest and AZtrauma have received FDA clearance.
  • Rayvolve software consistently delivers high-fidelity image interpretation and dependable triage support.
  • AZchest has shown high sensitivity in detecting lung nodules and improved sensitivity for radiologists when aided by the software.
  • Rayvolve detects fractures with high sensitivity and specificity.
  • The software is rigorously validated by leading institutions and backed by clinical research.

Limitations

  • No specific product or company reviews found on G2, Glassdoor, Capterra, or Reddit for AZmed SAS.
  • Limited information available regarding employer reviews for AZmed SAS specifically, with search results often conflating with other companies containing 'SAS' or 'AzMed' in their names.

Based on reviews from: AZmed Website, BioWorld, Indeed.com, accessdata.fda.gov, G2

Last updated: 2026-07-21

Videos

News, demos, and interviews about AZmed SAS.

Loading videos...

Videos load interactively. If none appear, search YouTube for AZmed SAS →

View all on YouTube

Press & Coverage

PRNewswire
AZmed Secures u20ac15 Million to Shape the Future of Medical Imaging with AI
AZmed, a European MedTech startup, has secured u20ac15 million in Series A funding to accelerate radiologists' workflows with AI in medical imaging. The investment will support strengthening its leadership in Europe and expanding globally, including the US, Middle East, Africa, and Asia.
2024-02
PR Newswire
AZmed Receives Two New FDA Clearances for Its AI-Powered Chest X-ray Solution
AZmed received two new FDA clearances for its AI tool AZchest, intended to assist radiologists in detecting lung nodules on chest X-rays and for triage capabilities for pneumothorax and pleural effusion. This builds on their previous FDA clearance for pediatric fracture detection.
2025-03
BioWorld
FDA clears Gleamer, Azmed AI-powered tools for chest X-rays | BioWorld
AZmed SAS received FDA clearance for Azchest, an AI-powered tool for chest X-rays to help radiologists detect lung nodules, pneumothorax, and pleural effusion. This follows their earlier FDA approval in 2022 for fracture detection software.
2025-04
Imaging Technology News
AZmed Receives FDA Clearance for AI-Powered Pediatric Fracture Detection Solution
AZmed received 510(k) clearance from the US FDA for its Rayvolve solution, which detects fractures on pediatric X-rays. A study with SimonMed Imaging demonstrated Rayvolve's high sensitivity (96%) and specificity (86%) in detecting pediatric fractures.
2024-09
Radiology Business
AZmed Expands FDA-Cleared AI Capabilities for X-Ray Trauma Detection
AZmed expanded its FDA clearance for AZtrauma to include the detection of joint effusions and dislocations on X-rays in adult and pediatric patients. This makes AZtrauma the only FDA-cleared AI solution in the US covering these three pathologies on X-rays.
2026-05
AZmed
AZmed Strengthens Regulatory Compliance with MDSAP Certification
AZmed received the Medical Device Single Audit Program (MDSAP) certification, ensuring its medical imaging solutions comply with regulations in the United States, Brazil, Australia, and Canada. This certification builds on previous ISO 13485, CE marking, and FDA clearances.
2025-02
PR Newswire
AZmed Expands Into CT Imaging With CE-Marked AZnod, An AI Tool for Lung Nodule Detection and the First Product in the Rayscanu00ae Line
AZmed announced the CE marking of AZnod, its first AI tool for computed tomography (CT) within the new Rayscanu00ae product line, expanding its portfolio beyond X-rays to include advanced CT-based analysis for lung nodule detection.
2025-12
AZmed
AZmed and RADIN Health partner to bring AI radiology tools to U.S. hospitals, imaging centers, and radiology practices
AZmed and RADIN Health formed a strategic distribution agreement to make AZmed's Rayvolveu00ae products, including AZtrauma and AZchest, available across RADIN's network of US healthcare facilities. This partnership aims to improve workflow efficiency and diagnostic support for radiologists.
2026-04

Frequently Asked Questions

AZmed offers the Rayvolveu00ae AI Suite, which includes AZtrauma for detecting fractures, dislocations, and joint effusions on X-rays, and AZchest for identifying lung nodules, pneumothorax, pleural effusion, and other chest abnormalities on X-rays. Additionally, their Rayscanu00ae line features AZnod, an AI tool for lung nodule detection and characterization on CT scans.
AZmed's AI solutions are designed to enhance diagnostic accuracy, reduce interpretation time, and prioritize critical cases, thereby streamlining radiology workflows. Clinical studies have demonstrated increased sensitivity for radiologists using AZmed's AI and significant reductions in reading time, helping to mitigate diagnostic errors and manage increasing workloads.
AZmed's products, including AZtrauma and AZchest, are FDA-cleared in the United States and hold CE marks in Europe. The company also maintains ISO 13485 certification and has received MDSAP certification, ensuring compliance with international medical device regulations across multiple countries.
AZchest is FDA-cleared for lung nodule detection and for triage of pneumothorax and pleural effusion on chest X-rays, demonstrating high sensitivity and specificity in clinical studies. For CT scans, AZnod provides standardized detection and characterization of pulmonary nodules between 3mm and 30mm, aiding lung cancer screening programs.
AZmed's AI suite, Rayvolveu00ae, is designed for seamless integration into existing PACS and RIS systems, functioning as a background clinical support tool. It analyzes images and provides outputs for worklist prioritization and structured reporting without altering the radiologist's primary reading process.
While specific pricing models are not publicly detailed, AI medical imaging solutions typically operate on a subscription or per-study basis, reflecting the value of enhanced diagnostic efficiency and accuracy. AZmed emphasizes seamless integration and provides robust support through its partnerships and direct channels to ensure optimal performance and user satisfaction.
Founded in 2018, AZmed has demonstrated strong growth, securing u20ac15 million in Series A funding and deploying its solutions in over 2,500 healthcare facilities across 55+ countries. They have strategic partnerships with entities like RADIN Health in the U.S., Healthinc in Australia/New Zealand, and Medical Horizons in Eastern Europe and the Middle East, expanding their global reach and support network.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.